HIS
RYTM icon

Harvest Investment Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Harvest Investment Services’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22M Buy
48,468
+4,515
+10% +$439K 0.77% 32
2025
Q4 		$4.7M Sell
43,953
-4,187
-9% -$444K 0.89% 25
2025
Q3 		$4.86M Buy
48,140
+32,674
+211% +$3.03M 0.98% 21
2025
Q2 		$977K Buy
+15,466
New +$947K 0.22% 116
2022
Q4 		– Sell
-13,941
Closed -$341K – 136
2022
Q3 		$341K Buy
+13,941
New +$259K 0.42% 75

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Harvest Investment Services's RYTM Position: Q1 2026 in Review

Harvest Investment Services increased its Rhythm Pharmaceuticals (RYTM) stake by 10% in Q1 2026, buying an estimated $439K and bringing the position to 48,468 shares worth $4.22M. The position accounts for 0.77% of the portfolio, ranked #32.

Harvest Investment Services first reported a position in RYTM in Q3 2022 and has held it in 5 quarters since. The position peaked at $4.86M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Harvest Investment Services held 48,468 shares of Rhythm Pharmaceuticals worth $4.22M as of Q1 2026.
  • Harvest Investment Services bought 4,515 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $439K.
  • Rhythm Pharmaceuticals made up 0.77% of Harvest Investment Services's portfolio in Q1 2026, its #32 holding.
  • Harvest Investment Services first reported a position in Rhythm Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • Harvest Investment Services's Rhythm Pharmaceuticals position peaked at $4.86M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Harvest Investment Services's 13F filing for Q1 2026, filed 15 May 2026.